Form 4 Innospec Inc: Leslie J. Parrette (Director) For: 10 November By Investing.com
This article reports on a Form 4 filing for Innospec Inc., detailing transactions by Director Leslie J. Parrette on November 10th. The filing indicates insider activity for the company, Innospec Inc. (IOSP).
Innospec (IOSP) Lifted Earnings And Dividend, Is The Recent Pullback A Buying Opportunity?
Innospec (IOSP) recently reported increased third-quarter and year-to-date earnings for 2026 and announced a 9% rise in its annual dividend. Despite these positive developments, the company's share price has experienced a significant pullback. Analysts at Simply Wall St view the stock as undervalued, suggesting the dip might present a buying opportunity based on its fair value of $101.
Innospec's Q3 Earnings Beat Estimates on Chemicals Strength
Innospec Inc. (IOSP) reported strong third-quarter 2026 adjusted earnings of $1.29 per share, surpassing the Zacks Consensus Estimate, driven by robust performance in its Performance Chemicals and Oilfield Services segments. Revenues increased 7.2% year-over-year to $473.6 million, though they slightly missed consensus estimates. The company maintains a debt-free balance sheet and anticipates continued growth, especially from efficiency upgrades in Performance Chemicals and improved Oilfield Services activity.
Learn Why The Bull Case For Innospec (IOSP) Could Change Following Earnings And Dividend Raise
Innospec reported strong third-quarter 2026 results with higher sales and net income, leading to a 9% increase in its full-year dividend to US$1.86 per share. This performance supports the company's investment narrative, but concerns about cash conversion and the dividend's coverage by free cash flow remain. Future performance hinges on the success of Performance Chemicals plant optimization and Oilfield Services expansion.
Analysts Are Updating Their Innospec Inc. (NASDAQ:IOSP) Estimates After Its Third-Quarter Results
Innospec Inc. (NASDAQ:IOSP) shares crashed 20% after its third-quarter results, despite revenue being in line with forecasts and EPS beating expectations. Analysts have reconfirmed their price target of US$101 and maintain their revenue and EPS forecasts for 2027, indicating no major change in the business's prospects or intrinsic value. The company is still expected to grow faster than the wider industry.
Innospec Projects 2027 Free Cash Flow of $55 Million to $60 Million
Innospec projects free cash flow of $55 million to $60 million in 2027, contingent on stable raw-material costs and reduced working capital. The company also expects fourth-quarter 2026 free cash flow of $40 million to $50 million and plans to commission efficiency upgrades at its North Carolina plant by year-end to boost capacity and productivity. For the quarter ended September 30, 2026, Innospec reported revenue of $473.6 million, up 7% year-over-year, and net income of $31.8 million.
Innospec Q3 2026 Earnings Call Transcript
Innospec Inc. reported strong third-quarter 2026 financial results, with total revenues increasing by 7% to $473.6 million and net income significantly rising to $31.8 million. The Performance Chemicals segment saw an 84% increase in operating income, and plant upgrades are expected to further boost growth. The company maintains a strong cash position with no debt, approved a 9% dividend increase, and anticipates stronger cash generation in upcoming quarters.
Sales rise 7% at Innospec (IOSP), while Q3 profit more than doubles.
Innospec (IOSP) reported a significant increase in its third-quarter 2026 financial results, with net sales rising 7% to $473.6 million and net income attributable to Innospec more than doubling to $31.8 million from $12.9 million a year earlier. Diluted earnings per share increased to $1.29 from $0.52. Despite a decline in nine-month operating cash flow, the company maintained a strong cash position of $251.9 million and an undrawn $250.0 million revolving credit facility.
Innospec Raises Semiannual Dividend 2.2% to $0.94 Per Share
Innospec Inc. (IOSP) has increased its semiannual dividend by 2.2% to $0.94 per share. Shareholders of record by November 17th will receive the payment on November 25th, with November 17th also serving as the ex-dividend date. The new payout offers a forward yield of 1.89%.
Innospec Q3 results: EBITDA up 16%, dividend raised by 9%
Innospec Inc. reported strong Q3 2026 results with adjusted EPS of $1.29, beating estimates by 1.57%, and adjusted EBITDA rising 16.29% to $51.4 million. While quarterly sales of $473.6 million slightly missed forecasts, they increased 7.17% year-over-year. The company also declared a semi-annual dividend of 94 cents per share, representing a 9% annual increase.
Innospec raises dividend by 2.2% to $0.94/share
Innospec (IOSP) has announced a semi-annual dividend of $0.94 per share, representing a 2.2% increase from its previous dividend of $0.92. This translates to a forward yield of 1.89%. The dividend is payable on November 25th to shareholders of record as of November 17th, with the ex-dividend date also on November 17th.
Innospec REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
Innospec reported strong third-quarter 2026 financial results, with revenue up 7% to $473.6 million and diluted EPS of $1.29, significantly higher than the previous year. The company's board also increased the semi-annual dividend by 9% to 94 cents per share, bringing the annual payout to $1.86. Performance Chemicals and Oilfield Services drove the operating income growth, while Fuel Specialties remained stable.
Innospec earnings loom with revenue test after strong quarter By Investing.com
Innospec Inc. (IOSP) is set to report third-quarter earnings, with analysts expecting $1.27 EPS and $478.34 million in revenue, a sequential decline but year-over-year growth. Investors will focus on the specialty chemicals maker's ability to maintain pricing power and volume, especially within its Fuel Specialties division, given the market's transition to fuel-efficient and high-performance engines and the growing demand for renewable diesel and sustainable aviation fuel. The company's prior quarter saw a significant beat on both earnings and revenue, setting high expectations despite anticipated sequential revenue softening.
How Innospec Inc. (IOSP) Affects Rotational Strategy Timing
Innospec Inc. (IOSP) shows strong sentiment across all time horizons, supporting an overweight bias according to AI models. The analysis identifies a mid-channel oscillation pattern and an exceptional 25.0:1 risk-reward short setup. Three distinct trading strategies are provided: a Position Trading Strategy, a Momentum Breakout Strategy, and a Risk Hedging Strategy, each with specific entry, target, and stop-loss zones.
Innospec (IOSP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Innospec (IOSP) is expected to report an increase in earnings and higher revenues for the quarter ended September 2026, with an earnings report anticipated on November 3. While the Zacks Consensus Estimate projects a 13.4% year-over-year EPS growth and 10.8% revenue increase, the Most Accurate Estimate is slightly lower, leading to a negative Earnings ESP. Combined with a Zacks Rank #3 (Hold), this makes it difficult to definitively predict an earnings beat despite the company's strong history of surpassing estimates.
Innospec Inc stock hits 52-week high at 100.48 USD
Innospec Inc. (IOSP) stock has hit a 52-week high of $100.48, reflecting a 33.41% increase over the past year and a market capitalization of $2.47 billion. InvestingPro analysis suggests the stock is undervalued, and the company has consistently raised its dividend for 12 years. This performance follows strong second-quarter 2026 financial results, which exceeded analyst expectations for both earnings per share and revenue.
Innospec (IOSP) Stock Could Be 25% Undervalued Despite Steady Cash Flow
A Simply Wall St analysis suggests Innospec (IOSP) stock could be 25% undervalued based on a Discounted Cash Flow (DCF) model, projecting significant free cash flow growth. Despite a 35% return over the past year, the current share price of $99.18 is considered meaningfully below its estimated intrinsic value. The valuation hinges on Innospec's ability to convert upgraded capacity and R&D spending into stronger cash generation, supporting the view that the specialty chemicals group is a steady cash generator.
Innospec Inc stock hits 52-week high at 100.48 USD By Investing.com
Innospec Inc. (IOSP) stock has reached a new 52-week high of $100.48, reflecting a 33.41% increase over the past year and a market capitalization of $2.47 billion. Despite this surge, InvestingPro analysis suggests the stock is still undervalued, backed by the company's consistent dividend increases for 12 consecutive years. This performance follows strong second-quarter 2026 financial results, which surpassed analyst expectations for both adjusted earnings per share and revenue.
Innospec Inc. Estimates – NASDAQ:IOSP
The article provides an overview of Innospec Inc. (NASDAQ: IOSP) financial estimates, covering reported financial data and analyst estimates for its income statement, balance sheet, cash flow statement, and valuation metrics. It highlights the ability to compare actual results with average, high, and low estimates and visualize trends over time. The content explicitly states that it is not investment advice.
Innospec schedules November 3 results for Innospec stock investors
Innospec Inc. (IOSP) is set to release its third-quarter 2026 results on November 3, 2026, after market close, followed by a conference call on November 4. This follows a strong second quarter where revenue rose 11.80% year-over-year to USD 491.40 million and EPS reached USD 1.27, exceeding estimates. The stock, currently trading below its yearly high, is being closely watched by investors for the upcoming report.
Argus lowers target to USD 102.00 for Innospec stock
Argus has lowered its price target for Innospec (IOSP) stock to USD 102.00, which is 5.36% above its recent Nasdaq closing price of USD 96.81. The company reported an 11.80% increase in second-quarter revenue to USD 491.40 million, with net income rising to USD 30.80 million. Innospec's third-quarter earnings are scheduled for November 3, 2026.
Innospec stock has third-quarter results scheduled for November 3, 2026
Innospec is scheduled to release its third-quarter 2026 results on November 3, 2026, with a subsequent conference call on November 4, 2026. The company reported a second-quarter revenue of USD 491.40 million, an 11.80% increase year-over-year, and diluted earnings per share of USD 1.25. As of October 15, 2026, Innospec's stock was trading at USD 96.60, with a P/E ratio of 19.71 and a market capitalization of USD 2.4 billion.
Technical Reactions to IOSP Trends in Macro Strategies
This article provides a technical analysis of Innospec Inc. (NASDAQ: IOSP) revealing a near-term neutral sentiment while mid and long-term outlooks remain strong. It highlights an exceptional risk-reward short setup and outlines specific institutional trading strategies including position trading, momentum breakout, and risk hedging, all based on AI models. The analysis also presents multi-timeframe signal data indicating support and resistance levels.
Innospec schedules November results and Innospec stock costs EUR 87.50
Innospec has scheduled its Q3 2026 earnings release for November 3, 2026, with a conference call on November 4, 2026. The company's Q2 2026 revenue was USD 491.40 million, an 11.80% increase year-over-year, and adjusted earnings per share exceeded consensus estimates. Innospec stock (IOSP) was trading at EUR 87.50 on October 8, 2026, marking a slight increase from its previous close.
Innospec Inc. (IOSP) Stock Forecasts
Argus has raised its target price for Innospec Inc. (IOSP) to $103.00, noting the company's current stock price is $96.18. Innospec Inc. manufactures and sells various chemicals and fuel additives, organizing its operations into three product-based segments. The report is available for download and is part of premium research offerings.
Innospec Q2 2026 Earnings Call: Complete Transcript
Innospec (NASDAQ: IOSP) reported a strong Q2 2026 with a 12% revenue increase to $491.4 million, driven by double-digit growth across all segments. Performance Chemicals saw a 9% revenue rise and 15% operating income growth, with plant repairs expected to finish by Q4 2026. Fuel Specialties revenue grew 12%, though gross margins slightly declined due to sales mix, while Oilfield Services revenue increased 14% with a 40% rise in operating income, boosted by DRA plant expansions and Middle East opportunities. The company maintains a strong balance sheet with $250.2 million in cash and no debt, supporting strategic initiatives, shareholder returns, and anticipated operating income growth in the second half of 2026.
A passive holder reports voting power over 1.16 million Innospec (IOSP) shares.
Allspring Global Investments Holdings, LLC has reported a passive stake of 4.7% in Innospec Inc. (IOSP), holding 1,161,421 common shares as of September 30, 2026. The firm disclosed sole voting power over 1,160,597 shares and sole dispositive power over all 1,161,421 shares, with no shared voting or dispositive powers. This information was filed via a SCHEDULE 13G, indicating the shares are beneficially owned by clients of investment advisers.
Allspring Global Investments Lowers Innospec Stake to 4.7% in Latest SEC Filing
Allspring Global Investments Holdings, LLC has reduced its beneficial ownership in Innospec Inc. to 4.7%, as disclosed in its latest SEC filing (Amendment No. 6 to Schedule 13G). As of September 30, 2026, Allspring Global Investments holds 1,161,421 shares of Innospec common stock, maintaining sole voting and dispositive power over these shares, with no single client owning more than 5%.
One investment manager reports 1.16M Innospec (IOSP) shares held for clients.
Allspring Global Investments Holdings, LLC reported a passive ownership of 1,161,421 shares of Innospec Inc. (IOSP) common stock, accounting for 4.7% of the class, as of September 30, 2026. The shares are held by clients of Allspring's investment-adviser subsidiaries, with no single client holding more than 5% of the class. Allspring exercises sole voting power over 1,160,597 shares and sole dispositive power over all 1,161,421 shares.
Form SCHEDULE 13G INNOSPEC INC. Filed by: Allspring Global Investments Holdings, LLC
Allspring Global Investments Holdings, LLC has filed a Schedule 13G form with the SEC concerning its beneficial ownership in Innospec Inc. The filing indicates that Allspring Global Investments Holdings, LLC beneficially owns 1,161,421 shares, representing 4.7% of the class of Innospec Inc.'s common stock. This filing is made under the Securities Exchange Act of 1934, indicating an ownership interest below 5% and not for the purpose of changing or influencing control of the issuer.
Innospec Inc. (IOSP) Stock Forecasts
Argus has raised its target price for Innospec Inc. (IOSP) to $102.00, citing the company's manufacturing and sale of various chemicals and fuel additives. The firm is organized into three segments based on product type. The current price of IOSP stock is $95.65.
Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call
Innospec Inc. (NASDAQ: IOSP) has announced it will release its third quarter 2026 earnings results on Tuesday, November 3, 2026, after market close. A conference call hosted by President and CEO Patrick S. Williams and CFO Ian Cleminson will follow on Wednesday, November 4, 2026, at 9:00 a.m. ET, for which the public can register to listen. The call will also be webcast on the company's website, innospec.com.
Form 4 Innospec Inc For: 5 October By Investing.com
This article announces a Form 4 filing for Innospec Inc. on October 5th, as reported by Investing.com. It is a brief, factual update regarding a regulatory filing for the company IOSP. The article itself is very short and provides no further details beyond the filing announcement.
Innospec Senior VP Ian McRobbie Awarded 3,164 Phantom Stock Shares with Staggered Vesting
Ian Malcolm McRobbie, Senior Vice President of Research and Technology at Innospec Inc., received 3,164 phantom stock shares on October 1, 2026, as per a Form 4 filing. These shares, granted at no cost, are equivalent to one share of IOSP common stock each and will vest in a staggered schedule: 25% on February 1, 2027, 25% on October 1, 2027, and 50% on October 1, 2028, contingent on his continued employment. Following this transaction, McRobbie beneficially owns 3,164 derivative securities.
A 4,792-unit CFO award at Innospec (IOSP) ties vesting to continued employment and satisfactory performance.
Innospec Inc.'s EVP & CFO, Ian Cleminson, received an award of 4,792 phantom stock units on October 1, 2026. These units are equivalent to common shares and will vest over time, with conditions tied to his continued employment and satisfactory performance. The vesting schedule is set for 25% on February 1, 2027, 25% on October 1, 2027, and the final 50% on October 1, 2028.
Form 4 Innospec Inc For: 5 October By Investing.com
This article from Investing.com reports on a Form 4 filing for Innospec Inc., dated October 5th. Form 4s are SEC documents that must be filed by company insiders when they trade shares of their own company's stock, providing transparency on insider transactions. The article provides the title and source, indicating an official regulatory filing related to Innospec Inc.
Form 4 Innospec Inc For: 5 October By Investing.com
This article announces the filing of Form 4 for Innospec Inc. on October 5th, as reported by Investing.com. It is a brief news update focusing solely on this regulatory filing for the company IOSP. The article also includes various market data and other news but the main content is about the Form 4.
Form 4 Innospec Inc For: 5 October By Investing.com
The article is a financial news brief announcing a Form 4 filing for Innospec Inc. for October 5th. It is published by Investing.com and includes the stock symbol IOSP. The content primarily serves as a placeholder for a regulatory filing announcement.
Innospec SVP Louis Hardy Griffin III Acquires 2,685 Phantom Stock Units Vesting by 2028
Innospec Inc.'s Senior Vice President of Human Resources, Louis Hardy Griffin III, acquired 2,685 phantom stock units on October 1, 2026. These units, which were acquired at no cost, are equivalent to one share of IOSP common stock each. The vesting schedule for these units is staggered, with portions vesting on February 1, 2027, October 1, 2027, and October 1, 2028, provided Griffin remains employed and performs satisfactorily.
Form 4 INNOSPEC INC. For: Oct 01 Filed by: Cleminson Ian
This Form 4 filing details insider transactions at Innospec Inc. (IOSP) by EVP & CFO Ian Cleminson. On October 1, 2026, Cleminson was granted 4,792 shares of phantom stock, which are economically equivalent to common stock and will vest over time. The filing provides a breakdown of the vesting schedule, with full vesting by October 1, 2028.
Form 4 INNOSPEC INC. For: Oct 01 Filed by: GRIFFIN HARDY LOUIS III
This Form 4 filing indicates that Griffin Hardy Louis III, SVP of Human Resources at Innospec Inc. (IOSP), was granted 2,685 shares of phantom stock on October 1, 2026. The phantom stock is equivalent to one share of common stock and will vest in tranches between February 2027 and October 2028, contingent on continued employment and performance. The filing details the transaction and the vesting schedule for the derivative securities.
Innospec stock reaches a new 52-week high as earnings beat estimates
Innospec stock reached a new 52-week high after the company reported second-quarter earnings per share of $1.27, exceeding the estimated $1.05. Revenue also surpassed expectations, reaching $491.40 million. While analysts' views on the stock remain divided, the company's strong financial performance drove its stock price higher.
Innospec Inc. to Report Third Quarter 2026 Earnings on November 3, 2026
Innospec Inc. will report its third-quarter 2026 earnings on November 3, 2026, after market close, followed by a conference call on November 4, 2026, hosted by President and CEO Patrick S. Williams and Executive VP and CFO Ian Cleminson. Interested parties must register for the call, and an audio webcast will be available on the company's website. The company, a global specialty chemicals provider, emphasized that actual results may differ from forward-looking statements due to risks and uncertainties.
Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call
Innospec Inc. (NASDAQ: IOSP) has announced it will release its third-quarter 2026 earnings results on Tuesday, November 3, 2026, after market close. A conference call with President and CEO Patrick S. Williams and EVP and CFO Ian Cleminson will follow on Wednesday, November 4, 2026, at 9:00 a.m. ET, and can be accessed via an online registration link or webcast on the company's website.
Innospec Schedules Third Quarter 2026 Earnings Release and Conference Call
Innospec Inc. announced it will release its third-quarter 2026 earnings results on Tuesday, November 3, 2026, after market close. Following the release, President and CEO Patrick S. Williams and EVP and CFO Ian Cleminson will host a conference call on Wednesday, November 4, 2026, at 9:00 a.m. ET. The public can register for the call or access a webcast on the company's website.
Innospec Inc. (0JAX.L) Stock Price, News, Quote & History
This Yahoo Finance page provides an overview of Innospec Inc. (0JAX.L) stock, including its current price, a summary, and links to news, research, and historical data. As of October 5th, the stock closed at 98.20 USD, up 0.61% for the day. No research reports were available for this ticker at the time of publication.
Innospec sets a 52-week high and Innospec stock gains 2.65 percent
Innospec (IOSP) stock reached a new 52-week high of USD 100.48 and gained 2.65 percent, trading at EUR 87.00. The specialty chemicals company reported strong Q2 2026 revenues of USD 491.40 million, surpassing expectations, with adjusted earnings per share also beating consensus estimates. Analysts maintain a "Buy" rating with a price target of USD 110.00, indicating further potential upside.
Avient Advances Circularity by Launching Nymax FR REC Flame Retardant
Avient has launched Nymax FR REC flame-retardant recycled polyamide grades to meet the increasing demand for sustainable materials, particularly in electrification and circularity initiatives. These new grades offer non-halogenated fire safety and contain 42-77% post-industrial recycled content, aligning with global electrical safety standards and regulatory requirements. The company, along with peers like Innospec, Quaker Chemical, and Cabot, is focusing on sustainability and growth, with Avient raising its full-year 2026 adjusted earnings guidance.
Innospec Inc stock hits 52-week high at 97.2 USD By Investing.com
Innospec Inc. (IOSP) has reached a 52-week high of $97.2, reflecting strong performance with a 44% gain over six months and a 24.1% increase over one year. InvestingPro analysis indicates the stock is undervalued, and the company has a "GOOD" financial health score, actively buying back shares and consistently raising dividends for 12 consecutive years. This milestone follows better-than-expected Q2 2026 earnings, with adjusted EPS at $1.27 and revenue at $491.4 million, surpassing analyst predictions.
Innospec Inc stock hits 52-week high at 97.2 USD By Investing.com
Innospec Inc. (IOSP) has reached a 52-week stock high of $97.2, reflecting strong performance and investor confidence. The company's stock has seen a 44% gain over six months and a 24.1% increase in a year, currently trading at $95.98. InvestingPro analysis indicates the stock is undervalued, and the company has consistently raised dividends for 12 consecutive years, alongside recent better-than-expected Q2 2026 earnings.